564 related articles for article (PubMed ID: 15006552)
1. Effects of enhancing mitochondrial oxidative phosphorylation with reducing equivalents and ubiquinone on 1-methyl-4-phenylpyridinium toxicity and complex I-IV damage in neuroblastoma cells.
Mazzio EA; Soliman KF
Biochem Pharmacol; 2004 Mar; 67(6):1167-84. PubMed ID: 15006552
[TBL] [Abstract][Full Text] [Related]
2. The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro.
Mazzio EA; Reams RR; Soliman KF
Brain Res; 2004 Apr; 1004(1-2):29-44. PubMed ID: 15033417
[TBL] [Abstract][Full Text] [Related]
3. D-(+)-glucose rescue against 1-methyl-4-phenylpyridinium toxicity through anaerobic glycolysis in neuroblastoma cells.
Mazzio E; Soliman KF
Brain Res; 2003 Feb; 962(1-2):48-60. PubMed ID: 12543455
[TBL] [Abstract][Full Text] [Related]
4. MPP(+)-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport.
Desai VG; Feuers RJ; Hart RW; Ali SF
Brain Res; 1996 Apr; 715(1-2):1-8. PubMed ID: 8739616
[TBL] [Abstract][Full Text] [Related]
5. Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I.
Plecitá-Hlavatá L; Jezek J; Jezek P
Int J Biochem Cell Biol; 2009; 41(8-9):1697-707. PubMed ID: 19433311
[TBL] [Abstract][Full Text] [Related]
6. MPP(+) causes inhibition of cellular energy supply in cerebellar granule cells.
González-Polo RA; Soler G; Alonso JC; Rodríguez-Martín A; Fuentes JM
Neurotoxicology; 2003 Mar; 24(2):219-25. PubMed ID: 12606294
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of coenzyme Q(10) prevents cytochrome c release from mitochondria induced by 1-methyl-4-phenylpyridinium ion in mouse brain synaptosomes.
Mitsumoto Y; Kobayashi S; Matsushima H; Muroyama A; Yoshimura I
Neurosci Lett; 2009 Sep; 463(1):22-5. PubMed ID: 19638300
[TBL] [Abstract][Full Text] [Related]
8. Chromium(VI) interaction with plant and animal mitochondrial bioenergetics: a comparative study.
Fernandes MA; Santos MS; Alpoim MC; Madeira VM; Vicente JA
J Biochem Mol Toxicol; 2002; 16(2):53-63. PubMed ID: 11979422
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium analogs in cultured neurons: relationship to the dopamine uptake system and inhibition of mitochondrial respiration.
Saporito MS; Heikkila RE; Youngster SK; Nicklas WJ; Geller HM
J Pharmacol Exp Ther; 1992 Mar; 260(3):1400-9. PubMed ID: 1312170
[TBL] [Abstract][Full Text] [Related]
10. Impaired glutamate clearance as a consequence of energy failure caused by MPP(+) in astrocytic cultures.
Di Monte DA; Tokar I; Langston JW
Toxicol Appl Pharmacol; 1999 Aug; 158(3):296-302. PubMed ID: 10438663
[TBL] [Abstract][Full Text] [Related]
11. Biphasic mechanism of the toxicity induced by 1-methyl-4-phenylpyridinium ion (MPP+) as revealed by dynamic changes in glucose metabolism in rat brain slices.
Maruoka N; Murata T; Omata N; Takashima Y; Fujibayashi Y; Wada Y
Neurotoxicology; 2007 May; 28(3):672-8. PubMed ID: 17391768
[TBL] [Abstract][Full Text] [Related]
12. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content.
Dhanasekaran M; Karuppagounder SS; Uthayathas S; Wold LE; Parameshwaran K; Jayachandra Babu R; Suppiramaniam V; Brown-Borg H
Life Sci; 2008 Jul; 83(3-4):92-5. PubMed ID: 18565546
[TBL] [Abstract][Full Text] [Related]
13. Role of mitochondrial dysfunction in neurotoxicity of MPP+: partial protection of PC12 cells by acetyl-L-carnitine.
Virmani A; Gaetani F; Binienda Z; Xu A; Duhart H; Ali SF
Ann N Y Acad Sci; 2004 Oct; 1025():267-73. PubMed ID: 15542726
[TBL] [Abstract][Full Text] [Related]
14. Iptakalim ameliorates MPP+-induced astrocyte mitochondrial dysfunction by increasing mitochondrial complex activity besides opening mitoK(ATP) channels.
Zhang S; Ding JH; Zhou F; Wang ZY; Zhou XQ; Hu G
J Neurosci Res; 2009 Apr; 87(5):1230-9. PubMed ID: 19006086
[TBL] [Abstract][Full Text] [Related]
15. Effects of resveratrol on the rat brain respiratory chain.
Zini R; Morin C; Bertelli A; Bertelli AA; Tillement JP
Drugs Exp Clin Res; 1999; 25(2-3):87-97. PubMed ID: 10370869
[TBL] [Abstract][Full Text] [Related]
16. Acetyl-L-carnitine cytoprotection against 1-methyl-4-phenylpyridinium toxicity in neuroblastoma cells.
Mazzio E; Yoon KJ; Soliman KF
Biochem Pharmacol; 2003 Jul; 66(2):297-306. PubMed ID: 12826272
[TBL] [Abstract][Full Text] [Related]
17. High doses of nicotinamide prevent oxidative mitochondrial dysfunction in a cellular model and improve motor deficit in a Drosophila model of Parkinson's disease.
Jia H; Li X; Gao H; Feng Z; Li X; Zhao L; Jia X; Zhang H; Liu J
J Neurosci Res; 2008 Jul; 86(9):2083-90. PubMed ID: 18381761
[TBL] [Abstract][Full Text] [Related]
18. MPP(+) increases the vulnerability to oxidative stress rather than directly mediating oxidative damage in human neuroblastoma cells.
Lee HS; Park CW; Kim YS
Exp Neurol; 2000 Sep; 165(1):164-71. PubMed ID: 10964495
[TBL] [Abstract][Full Text] [Related]
19. Measurement of mitochondrial respiration in permeabilized murine neuroblastoma (N-2alpha) cells, a simple and rapid in situ assay to investigate mitochondrial toxins.
Steyn SJ; Pieterse DJ; Mienie LJ; Van der Schyf CJ
J Biochem Biophys Methods; 2005 Jan; 62(1):25-40. PubMed ID: 15656941
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation.
Fosslien E
Ann Clin Lab Sci; 2001 Jan; 31(1):25-67. PubMed ID: 11314862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
